Auteur A. VENTO

3 Documents disponibles écrits par cet auteur

Ajouter le résultat à votre sélection Affiner la recherche

Identifying new/emerging psychoactive substances at the time of COVID-19; A web-based approach

V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO | 2021
Dans Frontiers in Psychiatry (Vol.11, 2021) Article : Périodique

COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]

Plus d'info

Ajouter à la sélection

Lien externe

Novel opioids: Systematic web crawling within the e-psychonauts' scenario

D. ARILLOTTA ; F. SCHIFANO ; F. NAPOLETANO ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; E. AGUGLIA ; A. VENTO | 2020
Dans Frontiers in Neuroscience (Vol.14, 2020) Article : Périodique

Background: A wide range of novel psychoactive substances (NPSs) are regularly searched and discussed online by e-psychonauts. Among NPSs, the range of prescription/non-prescription opioids (fentanyl and non-fentanyl analogs) and herbal derivati[...]

Plus d'info

Ajouter à la sélection

Lien externe

The clinical challenges of synthetic cathinones

F. SCHIFANO ; F. NAPOLETANO ; D. ARILLOTTA ; C. ZANGANI ; L. GILGAR ; A. GUIRGUIS ; J. M. CORKERY ; A. VENTO | 2020
Dans British Journal of Clinical Pharmacology (Vol.86, n°3, March 2020) Article : Périodique

Aims: Within the new psychoactive substances (NPS) scenario, several hundred different molecules, mostly including synthetic cannabinoids and cathinones, have been identified so far. The aims of the paper were to: (i) identify the number of synt[...]

Plus d'info

Ajouter à la sélection